Delivery Order SPE2DB20D2001-SPE2DB23FM63H

Award Date 7/12/23
Potential Completion Date 7/13/23
Potential Value $16K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The $34,316.57 fixed-price delivery order is for the procurement of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of August 29, 2023 and was awarded on August 28, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,254.34, is for the delivery of Uroxatral 10 mg tablets to support federal healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Uroxatral 10 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,212.22 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 3, 2023, with a completion date of April 4, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of 4565611301 - UROXATRAL 10 MG TABLET 100S to the Defense Logistics Agency (DLA). The firm-fixed price contract, valued at $3,579.74, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 29, 2024 and was awarded on August 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $45,361.73 fixed-price delivery order is for the supply of UROXATRAL 10 MG TABLET 100S, a pharmaceutical product. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $38,469.12 Firm Fixed Price Delivery Order contract is for the supply of Uroxatral 10 mg tablets. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,025.13, is a delivery order for the supply of 4563551117 UROXATRAL 10 MG TABLET 100S. The contract has a firm fixed price and an ultimate completion date of February 6, 2024. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract...
This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of UROXATRAL 10 MG TABLET 100S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $140,956.54 and is a Firm Fixed Price Delivery Order with a completion date of September 28, 2023. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office division, a major pharmaceutical distributor. The $3,381.44 firm fixed price delivery order contract is for the supply of 100 tablets of the prescription drug Uroxatral 10 mg. The contract has an ultimate completion date of August 13, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued...
The U.S. Department of Defense's Medical Supply Chain (DLA Troop Support Medical) awarded a Delivery Order contract valued at $34,416.19 to the Corporate Office Division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of UROXATRAL 10 MG TABLET 100S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999.00 through December 31, 2025, which serves as the...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB23FM63H
    Delivery Order

This federal contract award is for the delivery of Uroxatral 10 mg tablets to the Defense Logistics Agency (DLA). The $16,468.98 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order with a firm fixed price and has a completion date of July 13, 2023.

Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 10:39 AM